CompoAtlas

Novanuit Sommeil 30 Gélules

Supplement recorded in Open Food Facts

This collaborative Open Food Facts record is dated: the date relates to an update of the record, rather than a formula check. The formula may have changed. Check the packaging. This product is not necessarily declared in France: Compl'Alim declarations are separate.

Open Food Facts: food supplements with a barcode and an ingredient list, retrieved 15 November 2026.

Data “Open Food Facts and its contributors”, licensed under ODbL 1.0; derived table distributed under the same licence.

Brand
Sanofi
Barcode
3582910065838
Countries listed in the record
France
Package quantity
30 gélules
Record date
21 March 2026

Open Food Facts record; Compl'Alim declarations in France.

Ingredient list as published

Extrait de feuilles de Mélisse (Melissa officinalis) (Support: Maltodextrine de blé), Amidon de maïs prégélatinisé, Gélatine (Agent d'enrobage), Extrait de parties aériennes de Passiflore (Passiflora incarnata) (Support: maltodextrine de maïs, dioxyde de silicium), Talc, Stéarate de Magnésium (Anti-agglomérants), Extrait de fleurs de Pavot de Californie (Eschscholzia californica) (Support: maltodextrine de maïs, dioxyde de silicium), Dioxyde de titane, noir brillant (Colorants), Mélatonine, Vitamine B6

Open Food Facts: food supplements with a barcode and an ingredient list, retrieved 15 November 2026.

Data “Open Food Facts and its contributors”, licensed under ODbL 1.0; derived table distributed under the same licence.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Extrait de feuilles de Mélisse Melissa officinalis
    Read the warning, when it applies and the studies cited

    LEMON BALM -MELISSA OFFICINALIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Melissae folium.. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 16 June2014. [Accessed 2023 October 27]. Available at: https://www.ema.europa.eu/en/medicines/herbal/melissae-folium

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Melissae folium.. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 16 June2014. [Accessed 2023 October 27]. Available at: https://www.ema.europa.eu/en/medicines/herbal/melissae-folium

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 26 April 2024

  • Extrait de parties aériennes de Passiflore Passiflora incarnata
    Read the warning, when it applies and the studies cited

    PASSIONFLOWER -PASSIFLORA INCARNATA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Sleep aid.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Berardi et al. 2002: DiPiro et al. 2002).

    Sources cited by Health Canada (2)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiological Approach, 5th edition. New York (NY): McGraw-Hill Co. Inc.; 2002

    Condition of application: Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf

    When using this product avoid taking with alcohol or products that cause drowsiness (EMA 2014; Brinker 2010).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf

    Health Canada monograph dated 29 November 2024

  • Extrait de fleurs de Pavot de Californie Eschscholzia californica
    Read the warning, when it applies and the studies cited

    CALIFORNIA POPPY - ESCHSCHOLZIA CALIFORNICA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Sleep aid.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists continuously for more than 4 weeks (chronic insomnia) (Berardi et al. 2002; Dipiro et al. 2002).

    Sources cited by Health Canada (2)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: a pathophysiologic approach, 5th edition. New York (NY): The McGraw-Hill Companies, Inc.; 2002.

    Condition of application: Other uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    When using this product avoid taking with alcohol or products that cause drowsiness and/or with analgesic properties (Brinker 2010; Mills and Bone 2005; Hoffmann 2003).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2015; Berardi et al. 2002).

    Sources cited by Health Canada (2)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • EMA 2015: European Medicines Agency. European Union herbal monograph on Eschscholzia californica Cham., herba London. (UK): Committee on Herbal Medicinal Products (HMPC); 2015. [Accessed 2024 March 1]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-eschscholzia-californica-cham-herba_en.pdf.

    Contraindications

    Do not use if you are pregnant (Brinker 2010; Blumenthal et al. 2000).

    Sources cited by Health Canada (2)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Download the derived table under ODbL 1.0 (photo transcriptions under CC BY-SA 3.0).

Composition analysis

Food supplement: the checks below follow French and EU rules and are in French.

Food supplement : 2 vitamins or minerals, 3 plantes, 10 other ingredients. The daily dose is not stated: the quantities read cannot establish whether a daily dose is met or exceeded. See the references below.

For a complete answer, add the daily dose stated on the packaging to the end of the text (for example, ‘1 capsule per day’) and the quantity table (‘per 2 capsules: vitamin C 80 mg…’), or paste the product page link in the ‘link’ field below: we read the list, table and dose from it.

A food supplement is read differently from a cosmetic: daily doses and plants are what matter. References: maximum dose per supplement in France (Order of 9 May 2006, not revised since November 2006), EFSAEuropean Food Safety Authority. safety limit for adults, list of authorised plants (Order of 24 June 2014).

Each row: the printed name, what we recognise (click for its page), the dose read, then its role in the product and the references that apply.

On the labelRecognised asDose readWhat to know
Extrait de feuilles de Mélisse Melissa officinalisMelissa officinalis L.not statedMelissa officinalis L. is on the list of plants allowed in food supplements (Order of 24 June 2014).
ANSES opinion of 19 April 2023 on this plant: see its page.
Support: Maltodextrine de bléOther ingredient, not identified in our sourcesnot statedno reference
Amidon de maïs prégélatiniséOther ingredient, not identified in our sourcesnot statedno reference
Gélatine (Agent d'enrobage)Other ingredient, not identified in our sourcesnot statedno reference
Extrait de parties aériennes de Passiflore Passiflora incarnataPassiflora incarnata L.not statedPassiflora incarnata L. is not on the plant list of the Order of 24 June 2014: this is not a prohibition (a product legally sold in another Union country may contain it).
ANSES opinion of 19 April 2023 on this plant: see its page.
Support: maltodextrine de maïsOther ingredient, not identified in our sourcesnot statedno reference
dioxyde de siliciumSiliciumnot statedDose not read: compare the one on the label with the references on the nutrient’s page.
TalcOther ingredient, not identified in our sourcesnot statedno reference
Stéarate de Magnésium (Anti-agglomérants)Other ingredient, not identified in our sourcesnot statedno reference
Extrait de fleurs de Pavot de Californie Eschscholzia californicaEschscholzia californica Cham.not statedEschscholzia californica Cham. is on the list of plants allowed in food supplements (Order of 24 June 2014).
ANSES opinion of 19 April 2023 on this plant: see its page.
Support: maltodextrine de maïsOther ingredient, not identified in our sourcesnot statedno reference
Dioxyde de titaneOther ingredient, not identified in our sourcesnot statedno reference
noir brillant (Colorants)Other ingredient, not identified in our sourcesnot statedno reference
MélatonineMélatoninenot statedno reference
Vitamine B6Vitamine B6not statedDose not read: compare the one on the label with the references on the nutrient’s page.

No dose reference in our sources for this name: it is not linked to any vitamin, mineral, plant or additive on our lists.

NRV: nutrient reference value, the daily reference intake for an adult set by Regulation (EU) No 1169/2011. Maximum dose in France: daily ceiling for a food supplement (Order of 9 May 2006). EFSA limit: intake not to be exceeded each day over the long term, including food.

During pregnancy or breastfeeding, or when taking medication, ask a doctor or pharmacist before taking a supplement.

Brand : Sanofi

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Novanuit Sommeil 30 Gélules”, https://compoatlas.com/en/supplements/barcodes/3582910065838-novanuit-sommeil-30-gelules-sanofi, updated 21 March 2026.

Enter to analyse, Shift+Enter for a new line